Cargando…

Using observational study data as an external control group for a clinical trial: an empirical comparison of methods to account for longitudinal missing data

BACKGROUND: Observational data are increasingly being used to conduct external comparisons to clinical trials. In this study, we empirically examined whether different methodological approaches to longitudinal missing data affected study conclusions in this setting. METHODS: We used data from one cl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Norvang, Vibeke, Haavardsholm, Espen A., Tedeschi, Sara K., Lyu, Houchen, Sexton, Joseph, Mjaavatten, Maria D., Kvien, Tore K., Solomon, Daniel H., Yoshida, Kazuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148529/ https://www.ncbi.nlm.nih.gov/pubmed/35643430 http://dx.doi.org/10.1186/s12874-022-01639-0

Ejemplares similares

Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study
por: Norvang, Vibeke, et al.
Publicado: (2018)

Comparative analyses of responsiveness between the Rheumatoid Arthritis Impact of Disease score, other patient-reported outcomes and disease activity measures: secondary analyses from the ARCTIC study
por: Holten, Karen, et al.
Publicado: (2018)

Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study
por: Uhlig, Till, et al.
Publicado: (2023)

Denosumab and incidence of type 2 diabetes among adults with osteoporosis: population based cohort study
por: Lyu, Houchen, et al.
Publicado: (2023)

12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this target
por: Uhlig, Till, et al.
Publicado: (2021)

One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study
por: Uhlig, Till, et al.
Publicado: (2022)

Course and predictors of work productivity in gout — results from the NOR-Gout longitudinal 2-year treat-to-target study
por: Uhlig, Till, et al.
Publicado: (2023)

Two-year reduction of dual-energy CT urate depositions during a treat-to-target strategy in gout in the NOR-Gout longitudinal study
por: Uhlig, Till, et al.
Publicado: (2021)

Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial
por: Nordberg, Lena Bugge, et al.
Publicado: (2018)

All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study
por: Kerola, Anne M, et al.
Publicado: (2022)

A high serum level of eotaxin (CCL 11) is associated with less radiographic progression in early rheumatoid arthritis patients
por: Syversen, Silje W, et al.
Publicado: (2008)

Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study
por: Paulshus Sundlisæter, Nina, et al.
Publicado: (2022)

Identification of SNPs associated with methotrexate treatment outcomes in patients with early rheumatoid arthritis
por: Kolan, Shrikant S., et al.
Publicado: (2022)

Rheumatoid factor and falsely elevated results in commercial immunoassays: data from an early arthritis cohort
por: Gehin, Johanna E., et al.
Publicado: (2021)

Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategy
por: Sundin, Ulf, et al.
Publicado: (2021)

Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment
por: Holten, Karen, et al.
Publicado: (2022)

An empirical evaluation of the impact of missing data on treatment effect
por: Joseph, Royes, et al.
Publicado: (2015)

Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: results from the NOR-VEAC cohort
por: Mjaavatten, Maria D, et al.
Publicado: (2009)

Imputing missing data of function and disease activity in rheumatoid arthritis registers: what is the best technique?
por: Mongin, Denis, et al.
Publicado: (2019)

Urate crystal deposition is associated with inflammatory markers and carotid artery pathology in patients with intercritical gout: results from the NOR-Gout study
por: Hammer, Hilde Berner, et al.
Publicado: (2022)

Accounting for missing data in statistical analyses: multiple imputation is not always the answer
por: Hughes, Rachael A, et al.
Publicado: (2019)

Empirical Comparison of Imputation Methods for Multivariate Missing Data in Public Health
por: Pan, Steven, et al.
Publicado: (2023)

Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study)
por: Syversen, Silje W, et al.
Publicado: (2020)

PELP: Accounting for Missing Data in Neural Time Series by Periodic Estimation of Lost Packets
por: Dastin-van Rijn, Evan M., et al.
Publicado: (2022)

Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
por: Uhlig, T., et al.
Publicado: (2022)

The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis
por: Mjaavatten, Maria D, et al.
Publicado: (2010)

Measuring the missing: greater racial and ethnic disparities in COVID-19 burden after accounting for missing race/ethnicity data
por: Labgold, Katie, et al.
Publicado: (2020)

Smoking status and cause-specific discontinuation of tumour necrosis factor inhibitors in axial spondyloarthritis
por: Zhao, Sizheng Steven, et al.
Publicado: (2019)

Analytical approaches and estimands to take account of missing patient-reported data in longitudinal studies
por: Bell, Melanie L, et al.
Publicado: (2019)

Missing data as data
por: Basiri, Anahid, et al.
Publicado: (2022)

An Empirical Attempt to Operationalize Chasing Losses in Gambling Utilizing Account-Based Player Tracking Data
por: Auer, Michael, et al.
Publicado: (2022)

Serious infections in patients with rheumatoid arthritis and psoriatic arthritis treated with tumour necrosis factor inhibitors: data from register linkage of the NOR-DMARD study
por: Christensen, Ingrid Egeland, et al.
Publicado: (2022)

Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approach
por: Aga, Anna-Birgitte, et al.
Publicado: (2016)

Accounting for one-channel depletion improves missing value imputation in 2-dye microarray data
por: Ritz, Cecilia, et al.
Publicado: (2008)

An empirical comparison of Bayesian modelling strategies for missing binary outcome data in network meta-analysis
por: Spineli, Loukia M.
Publicado: (2019)

Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial
por: Brun, Marthe Kirkesæther, et al.
Publicado: (2022)

Acquisition and analysis of raw accounting data
por: Landau, K
Publicado: (1974)

A Bayesian framework to account for uncertainty due to missing binary outcome data in pairwise meta‐analysis
por: Turner, N. L., et al.
Publicado: (2015)

Accounting for missing data caused by drug cessation in observational comparative effectiveness research: a simulation study
por: Mongin, Denis, et al.
Publicado: (2022)

Diagnostic spectrum and 2-year outcome in a cohort of patients with very early arthritis
por: Norli, Ellen Sauar, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bup84njoo8oir50vc4vjdteg3j